Nanobody stabilization of G protein-coupled receptor conformational states

被引:191
作者
Steyaert, Jan [1 ]
Kobilka, Brian K. [2 ]
机构
[1] Vrije Univ Brussel, Dept Mol & Cellular Interact, VIB & Struct Biol Brussels, B-1050 Brussels, Belgium
[2] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
DOMAIN ANTIBODY FRAGMENTS; CRYSTAL-STRUCTURE; TERNARY COMPLEX; AGONIST; ARRESTIN; RECOGNITION; RHODOPSIN;
D O I
10.1016/j.sbi.2011.06.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Remarkable progress has been made in the field of G protein-coupled receptor (GPCR) structural biology during the past four years. Several obstacles to generating diffraction quality crystals of GPCRs have been overcome by combining innovative methods ranging from protein engineering to lipid-based screens and microdiffraction technology. The initial GPCR structures represent energetically stable inactive-state conformations. However, GPCRs signal through different G protein isoforms or G protein-independent effectors upon ligand binding suggesting the existence of multiple ligand-specific active states. These active-state conformations are unstable in the absence of specific cytosolic signaling partners representing new challenges for structural biology. Came lid single chain antibody fragments (nanobodies) show promise for stabilizing active GPCR conformations and as chaperones for crystallogenesis.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 50 条
[1]  
ARNIS S, 1994, J BIOL CHEM, V269, P23879
[2]   Crystallizing Membrane Proteins for Structure Determination: Use of Lipidic Mesophases [J].
Caffrey, Martin .
ANNUAL REVIEW OF BIOPHYSICS, 2009, 38 :29-51
[3]   High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor [J].
Cherezov, Vadim ;
Rosenbaum, Daniel M. ;
Hanson, Michael A. ;
Rasmussen, Soren G. F. ;
Thian, Foon Sun ;
Kobilka, Tong Sun ;
Choi, Hee-Jung ;
Kuhn, Peter ;
Weis, William I. ;
Kobilka, Brian K. ;
Stevens, Raymond C. .
SCIENCE, 2007, 318 (5854) :1258-1265
[4]   Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist [J].
Chien, Ellen Y. T. ;
Liu, Wei ;
Zhao, Qiang ;
Katritch, Vsevolod ;
Han, Gye Won ;
Hanson, Michael A. ;
Shi, Lei ;
Newman, Amy Hauck ;
Javitch, Jonathan A. ;
Cherezov, Vadim ;
Stevens, Raymond C. .
SCIENCE, 2010, 330 (6007) :1091-1095
[5]  
CHOE HW, 2011, NATURE, P1
[6]   β-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae [J].
Conrath, KE ;
Lauwereys, M ;
Galleni, M ;
Matagne, A ;
Frère, JM ;
Kinne, J ;
Wyns, L ;
Muyldermans, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2807-2812
[7]   Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies [J].
De Genst, E ;
Silence, K ;
Decanniere, K ;
Conrath, K ;
Loris, R ;
Kinne, R ;
Muyldermans, S ;
Wyns, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (12) :4586-4591
[8]   Structure and Properties of a Complex of α-Synuclein and a Single-Domain Camelid Antibody [J].
De Genst, Erwin J. ;
Guilliams, Tim ;
Wellens, Joke ;
O'Day, Elizabeth M. ;
Waudby, Christopher A. ;
Meehan, Sarah ;
Dumoulin, Mireille ;
Hsu, Shang-Te Danny ;
Cremades, Nunilo ;
Verschueren, Koen H. G. ;
Pardon, Els ;
Wyns, Lode ;
Steyaert, Jan ;
Christodoulou, John ;
Dobson, Christopher M. .
JOURNAL OF MOLECULAR BIOLOGY, 2010, 402 (02) :326-343
[9]  
DELEAN A, 1980, J BIOL CHEM, V255, P7108
[10]   Energy Landscapes as a Tool to Integrate GPCR Structure, Dynamics, and Function [J].
Deupi, Xavier ;
Kobilka, Brian K. .
PHYSIOLOGY, 2010, 25 (05) :293-303